Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
about
Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment optionsCanadian practice guidelines for surgical intra-abdominal infectionsErtapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trialsPhase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infectionsAcquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infectionsEpileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.2013 WSES guidelines for management of intra-abdominal infections.Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescents[Characterization of bacterial flora in community peritonitis carried out in Burkina Faso].WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.A Comprehensive review of abdominal infections.Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.Management of peritonitis in the critically ill patientTigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisFactors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem.Peritonitis - the Western experience.Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control studyPharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients.The efficacy of combined therapy with metronidazole and broad-spectrum antibiotics on postoperative outcomes for pediatric patients with perforated appendicitis.
P2860
Q21146707-BC6EE1A5-6ADA-47DB-9033-F0A3296CA2B5Q24599288-F814320F-290B-4D00-8BA8-3FB965D14C92Q33516983-793B1FE2-535E-4B6A-8AB8-C8969A457313Q33622765-1B3922B6-078E-42C2-9048-C2F7F8DD4064Q33938132-A76FC782-8E13-4A51-A029-1600F0438693Q34026343-592F2C79-8140-4DAF-B4FD-B975570DF2C4Q34057425-0D101DC4-B7E3-4C59-8D43-C23F93C32411Q34321150-EB4DCBBF-98E7-4BC4-B919-00A11E59B07DQ34348830-4753B887-B865-412E-8FB1-5258F643EA8AQ34423201-0507E925-1265-4EBD-B120-1F5B1E5B9010Q34541183-7EBA9EBD-4FF8-47F9-A203-5E37EF6AD480Q34626144-B31B7D19-8D6F-433F-8B18-89D03DE03C50Q35545954-BC27ED88-8FD7-4BC1-BA73-AEAE669B5545Q35928948-B089EBB0-93D7-4F81-9127-2FA7777A3C1DQ36658471-E0456EBC-ACA1-43B9-B67E-5AE6702DE0CBQ36663656-F15EFDB3-5985-4963-AE5A-6E0DF2F015BCQ37125124-71B492DC-EDAF-4B1E-B89E-D5BB13268803Q37279923-A0F2E069-FEE5-43C3-ABC1-21FF3B5C9E94Q37412959-07F17BB6-17B2-4409-8510-E0197B3E219BQ38390757-513461C6-8CDF-4F52-8C2D-E9F3446E8C2FQ41185854-E99A89BD-9D14-4F31-AE88-F77C68D9A445Q41876999-DC407E09-1601-41EF-84DE-EF3B1B9F5111Q47095071-50AB1835-43CE-4F43-BE2B-F79BF832C09E
P2860
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Ertapenem versus piperacillin/ ...... d comparative phase III trial.
@ast
Ertapenem versus piperacillin/ ...... d comparative phase III trial.
@en
type
label
Ertapenem versus piperacillin/ ...... d comparative phase III trial.
@ast
Ertapenem versus piperacillin/ ...... d comparative phase III trial.
@en
prefLabel
Ertapenem versus piperacillin/ ...... d comparative phase III trial.
@ast
Ertapenem versus piperacillin/ ...... d comparative phase III trial.
@en
P2093
P1433
P1476
Ertapenem versus piperacillin/ ...... ed comparative phase III trial
@en
P2093
Albert E Yellin
Alexandra Carides
Alvaro Fernandez
E Patchen Dellinger
Hedy Teppler
Jose M Tellado
Kyuran A Choe
Nicolas V Christou
Ori D Rotstein
Osvaldo Malafaia
P304
P356
10.1097/00000658-200302000-00013
P407
P577
2003-02-01T00:00:00Z